Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to
Tesla Inc (NASDAQ: TSLA) has expanded access to its supercharger network to all electric cars in select locations in the United Kingdom and Europe, two months after making the service available in the Netherlands.